The global irbesartan tablets market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is anticipated to fuel the market during the forecast period includes an increasing prevalence of high blood pressure globally. Irbesartan is a class of drugs called angiotensin receptor blockers (ARBs). It is taken to treat high blood pressure, to protect the kidney in hypertensive type 2 diabetic patients with laboratory evidence of impaired renal. These tablets function by relaxing blood vessels so that blood can flow more easily. It can be taken with or without food, is available as the brand-name drug Avapro.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/irbesartan-tablets-market
Further, hypertension is a primary contributor to heart disease and stroke, the first and third leading causes of death globally. According to World Health Organization (WHO), an estimated 1.28 billion adults aged 30-79 years globally have hypertension, most (two-thirds) living in low- and middle-income countries. Furthermore, an estimated 46% adults with hypertension are unaware that they have the condition. The high prevalence of hypertension creates a huge public health burden. In the past three decades, the highest global blood pressure levels have moved from high-income countries to low-income countries in South Asia and sub-Saharan Africa due to opposite trends, while blood pressure has been determinedly high in central and eastern Europe which is driving the market growth during the forecast period. Furthermore, FDA’s voluntary recalls owing to suspects of cancer-causing chemicals and contamination are hindering the growth of the global irbesartan tablets market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Apotex Inc., Sanofi S.A., and Teva Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Irbesartan Tablets Market Report Segmentation
By Type
- 75 mg Tablets
- 150 mg Tablets
- 300 mg Tablets
By Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full report of Irbesartan Tablets Market is available at: https://www.omrglobal.com/industry-reports/irbesartan-tablets-market
Irbesartan Tablets Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Apotex Inc.
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
